Cite
MLA Citation
Devalingam Mahalingam et al.. “Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.” British journal of clinical pharmacology, vol. 86, no. 9, 2020, pp. 1836–1848. http://access.bl.uk/ark:/81055/vdc_100106940558.0x000051